Differential CDK-inhibitor gene expression in aging human diploid fibroblasts

Experimental Gerontology

Volumn 31, Issue 1-2, 1996, Pages 311-325

  Wong, Howard ^a   Riabowol, Karl ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

cell cycle; fibroblast aging; gene expression; senescence

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; ENZYME INHIBITOR; MESSENGER RNA; PROTEIN P21;

ARTICLE; CELL AGING; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; NEWBORN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE;

EID: 0029944622     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/0531-5565(95)00025-9     Document Type: Article

References (68)

1. ATADJA, P., WONG, H., VEILLETTE, C., and RIABOWOL, K.T. Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp. Cell. Res. 217, 205-216, 1995.
2. BUNN, C.L. and TARRANT, G.M. Limited lifespan in somatic cell hybrids and cybrids. Exp. Cell Res. 127, 385-396, 1980.
3. BURMER, C., ZEIGLER, C.J., and NORWOOD, T.H. Evidence for endogenous polypeptide-mediated inhibition of cell cycle transit in human diploid cells. J. Cell Biol. 94, 187-192, 1982.
4. CHOMCZYNSKI, P. and SACCHI, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159, 1987.
5. CRISTOFALO, V.J., DOGGETT, D.L., BROOKS-FREDERICH, K.M., and PHILLIPS, P.D. Growth factors as probes of cell aging. Exp. Gerontol. 24, 367-374, 1989.
6. DULIC, V., DRULLlNGER, L.F., LEES, E., REED, S.I., and STEIN, G.H. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: Accumulation of inactive E-Cdk2 and cyclin D1-Cdk2 complexes. Proc. Natl. Acad. Sci. USA 90, 11034-11038, 1993.
7. DULIC, V., KAUFMANN, W.K., WILSON, S.J., TISTY, T.D., LEES, E., HARPER, J.W., ELLEDGE, S.J., and REED, S.I. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76, 1013-1023, 1994.
8. EL-DEIRY, W.S., TOKINO, T., VELCULESCU, V.E., LEVY, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, E., KINZLER, K.W., and VOGELSTEIN, B. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825, 1993.
9. FISHER, R.P. and MORGAN, D.O. A novel cyclin associates with MO15/Cdk7 to form the CDK-activating kinase. Cell 78, 713-724, 1994.
10. FLORES-ROZAS, H., KELMAN, Z., DEAN, F.B., PAN, Z-Q., HARPER, J.W., ELLEDGE, S.J., O'DONNELL, M., and HURWITZ, J. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase deta holoenzyme. Proc. Natl. Acad. Sci. USA 91, 8655-8659, 1994.
11. FUTREAL, P.A. and BARRETT, J.C. Failure of senescent cells to phopsphorylate the RB protein. Oncogene 1109-1113, 1991.
12. GIRARD, F., STRAUSFELD, U., FERNANDEZ, A., and LAMB, N. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67, 1169-1179, 1991.
13. GOLDSTEIN, S. Replicative senescence: The human fibroblast comes of age. Science 249, 1129-1133, 1990.
14. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8, 2939-2952, 1994.
15. GYURIS, J., GOLEMIS, E., CHERTKOV, H., and BRENT, R. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75, 791-803, 1993.
16. HALEVY, O., NOVITCH, B.G., SPICER, D.B., SKAPEK, S.X., RHEE, J., HANNON, G.J., BEACH, D., and LASSAR, A.B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267, 1018-1021, 1995.
17. HAN, E.K., SGAMBATO, A., JIANG, W., ZHANG, Y.J., SANTELLA, R.M., DOKI, Y., CACACE, A.M., SCHIEREN I. and WEIMTEIN, I.B. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene 10, 953-961, 1995.
18. INK4B is a potent effector of TGF-β-induced cell cycle arrest. Nature 371, 257-261, 1994.
19. HARPER, J.W., ADAMI, G.R., WEI, N., KEYOMARSI, K., and ELLEDGE, S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816, 1993.
20. HARTWELL, L.H. and WEINERT, T.A. Checkpoints: Controls that ensure the order of cell cycle events. Science 246, 629-634, 1989.
21. HAYFLICK, L. The limited in vitro lifetime of human diploid fibroblasts. Exp. Cell Res. 37, 614-636, 1965.
22. HINDS, P.W., MITTNACHT, S., DULIC, V., ARNOLD, A., REED, S.I., and WEINBERG, R.A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70, 993-1006, 1992.
23. HUNTER, T. and PINES, J. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79, 573-582, 1994.
24. HUSSUSSIAN, C.J., STRUEWING, J.P., GOLDSTEIN, A.M., HIGGINS, P.T., ALLY, D.S., SHEAHAN, M.D., CLARK, W.H., JR., TUCKER, M.A., and DRACOPOLI, N.C. Germline p16 mutations in familial melanoma. Nature Genet. 8, 15-21, 1994.
25. JIANG, H., LIN, J., SU, Z-Z, COLLART, F.R., HUBERMAN, E., and FISHER, P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9, 3397-3406, 1994.
26. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STICKERT, E., DAY, R.F., JOHNSON, B.E., and SKOLNICK, M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436-440, 1994a.
27. KAMB, A., SHATTUCK-EIDENS, D., EELES, R., LIU, Q., GRUIS, N.A., DING, W., HUSSEY, C., TRAN, T., MIKI, Y., WEAVER-FELDHAUS, J., McCLURE, M., AITKEN, J.F., ANDERSON, D.E., BERGMAN, W., FRANTS, R., GOLDGAR, D.E., GREEN, A., MACLENNAN, R., MARTIN, N.G., MEYER, L.J., YOUL, P., ZONE, J.J., SKOLNICK, H.M., and CANNON-ALBRIGHT, L.A. Analysis of the p16 gene (cdkn2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet. 8, 22-26, 1994b.
28. LUMPKIN, C.K., McCLUNG, J.K., PEREIRA-SMITH, O.M., and SMITH, J.R. Existence of high abundance antiproliferative mRNAs in senescent human diploid fibroblasts. Science 232, 393-395, 1986.
29. LUCIBELLO, F.C., SEWING, A., BRUSSELBACH, S., BURGER, C., and MULLER, R. Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J. Cell Sci. 105, 123-133, 1993.
30. MACIERA-COELHO, A. and TABOURY, F. A reevaluation of the changes in proliferation in human fibroblasts during aging in vitro. Cell Tissue Kinet. 15, 213-224, 1982.
31. MAKELA, T.P., TASSAN, J.-P., NIGG, E.A., FRUTIGER, S., HUGHES, G.J., and WEINBERG, R.A. A cyclin associated with the CDK-activating kinase MO15. Nature 371, 254-257, 1994.
32. MATSUOKA, M., KATO, J-Y., FISHER, R.P., MORGAN, D.O., and SHERR, C.J. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell Biol. 14, 7265-7275, 1994.
33. MATSUSHIME, H., ROUSSEL, M., ASHMUN, R.A., and SHERR, C.J. Colony-stimulating factor regulates novel cyclins during the G1 phase of the cell cycle. Cell 65, 701-713, 1991.
34. PSK-J3cdk4) for mammalian D type G1 cyclins. Cell 71, 323-334, 1992.
35. McCORMICK, A. and CAMPISI, J. Cellular aging and senescence. Cell Biol. 3, 230-234, 1991.
36. MEYERSON, M. and HARLOW, E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14, 2077-2086, 1994.
37. MULLER, H., LUKAS, J., SCHNEIDER, A., WARTHOE, P., BARTEK, J., EILERS, M., and STRAUSS, M. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc. Natl. Acad. Sci. USA 91, 2945-2949.
38. MURANO, S., THWEATT, SHMOOKLER-REIS, R.J., JONES, R.A., MOERMAN, E.J., and GOLDSTEIN, S. Diverse gene sequences are overexpressed in Werner Syndrom fibroblasts undergoing premature replicative senescence. Mol. Cell Biol. 11, 3905-3914, 1991.
39. NOBORI, T., MIURA, K., WU, D.J., LOIS, A., TAKABAYASHI, K., and CARSON, D.A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753-756, 1994.
40. NODA, A., NING, Y., VENABLE, S.F., PEREIRA-SMITH, O.M., and SMITH, J.R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell. Res. 211, 90-98, 1994.
41. PAGANO, M., PEPPERKOK, R., VERDE, F., ANSORGE, W., and DRAETTA, G. Cyclin A is required at two points in the human cell cycle. EMBO J. 11, 961-971, 1992.
42. PAGANO, M., THEODORAS, A.M., TAM, S.W., and DRAETTA, G.F. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev. 8, 1627-1639, 1994.
43. PARDEE, A.B. G1 events and regulation of cell proliferation. Science 246, 603-608, 1989.
44. Cip1 in muscle and other terminally differentiating cells. Science 267, 1024-1027, 1995.
45. PEREIRA-SMITH, O.M. and SMITH, J.R. Evidence for the recessive nature of cellular immortality. Science 221, 964-966, 1983.
46. PEREIRA-SMITH, O.M., STEIN, G.H., ROBETORYE, S., and MEYER-DEMAREST, S. Immortal phenotype of the HeLa variant D98 is recessive in hybrids formed with normal human fibroblasts. J. Cell Physiol. 143, 222-225, 1990.
47. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22, 1994.
48. KIP1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78, 59-66, 1994.
49. RIABOWOL, K.T. Transcription factor activity during cellular aging of human diploid fibroblasts. Biochem. Cell Biol. 70, 1064-1072, 1992.
50. RIABOWOL, K.T., DRAETTA, G., BRIZUELA, L., VANDRE, D., and BEACH, D. The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells. Cell 57, 393-401, 1989.
51. RICHTER, K.H., AFSHARI, C.A., ANNAB, B.A., BURKHART, L.A., OWEN, R.D., BOYD, J., and BARRETT, J.C. Down-regulation of Cdc2 in senescent human and hamster cells. Cancer Res. 51, 6010-6013, 1991.
52. RITTLING, S.R., BROOKS, K.M., CRISTOFALO, V.J., and BASERGA, R. Expression of cell cycle-dependent genes in young and senescent WI-38 fibroblasts. Proc. Natl. Acad. Sci. USA 83, 3316-3320, 1986.
53. SERRANO, M., HANNON, G., and BEACH, D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/Cdk4. Nature 366, 704-707, 1993.
54. INK4. Science 267, 249-252, 1995.
55. SHERR, C.J. Mammalian G1 cyclins. Cell 73, 1059-1065, 1993.
56. SHERR, C.J. G1 phase progression: Cycling on cue. Cell 79, 551-555, 1994.
57. SKAPEK, S.X., RHEE, J., SPICER, D.B., and LASSAR, A.B. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267, 1022-1024, 1995.
58. STEIN, G.H., BEESON, M., and GORDON, L. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 249, 666-669, 1990.
59. STEIN, G.H., DRULLINGER, L.F., ROBETORYE, R.S., PEREIRA-SMITH, O.M., and SMITH, J.R. Senescent cells fail to express cdc2, cycA, and cycB in response to mitogen stimulation. Proc. Natl. Acad. Sci. USA 88, 11012-11016, 1991.
60. STEINMAN, R.A., HOFFMAN, B., IRO, A., GUILOUF, C., LIEBERMANN, D.A., and ELHOUSEINI, M.E. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9, 3389-3396, 1994.
61. TAM, S.W., THEODORAS, A.M., SHAY, J.W., DRAETTA, G.F., and PAGANO, M. Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: Association with Cdk4 is required for cyclin D1 function in G1 progression. Oncogene 9, 2663-2674, 1994.
62. TOYOSHIMA, H. and HUNTER, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74, 1994.
63. TSAI, L-W., LEES, E., FAHA, B., HARLOW, E., and RIABOWOL, K. The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene 8, 1593-1602, 1993.
64. WAGA, S., HANNON, G.J., BEACH, D., and STILLMAN, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-578, 1994.
65. WONG, H., ANDERSON, W.D., CHENG, T., and RIABOWOL, K.T. Monitoring mRNA expression by polymerase chain reaction: The 'primer-dropping' method. Anal. Biochem. 223, 251-258, 1994.
66. XIONG, Y., ZHANG, H., and BEACH, D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71, 505-514, 1992.
67. XIONG, Y., HANNON, G.J., ZHANG, H., CASSO, D., KOBAYASHI, R., and BEACH, D. p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704, 1993.
68. ZINDY, F., LAMAS, E., CHENIVESSE, X., SOBCZAK, J., WANG, J., FESQUET, D., HENGLEIN, B., and BRECHOT, C. Cyclin A is required in S phase in normal epithelial cells. Biochim. Biophys. Res. Commun. 182, 1144-1154, 1992.